| |
| |
|
| Insider
Information: |
Brannelly Paul |
| Relationship: |
Executive Vice Preside... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
281,564 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,328,525 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
281,564 |
|
|
| Total
Value |
$7,328,525 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
SVP, FINANCE & ADMIN, ... |
2014-05-15 |
66,136 |
|
0 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Executive Vice Preside... |
2021-02-10 |
215,428 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,913 |
77,376 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-05-13 |
4 |
A |
$15.02 |
$18,024 |
D/D |
1,200 |
78,576 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-05-16 |
4 |
A |
$15.73 |
$12,584 |
D/D |
800 |
79,376 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-05-17 |
4 |
A |
$15.46 |
$15,460 |
D/D |
1,000 |
80,376 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-05-18 |
4 |
A |
$16.00 |
$14,400 |
D/D |
900 |
81,276 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-05-20 |
4 |
A |
$16.89 |
$18,579 |
D/D |
1,100 |
82,376 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-07-29 |
4 |
A |
$10.31 |
$10,135 |
D/D |
983 |
83,359 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2017-01-27 |
4 |
A |
$10.08 |
$10,140 |
D/D |
1,006 |
84,365 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2017-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
100,615 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2017-07-28 |
4 |
A |
$10.60 |
$8,226 |
D/D |
776 |
111,003 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
133,803 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-01-26 |
4 |
A |
$10.17 |
$10,617 |
D/D |
1,044 |
134,847 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-07-27 |
4 |
A |
$15.84 |
$8,538 |
D/D |
539 |
123,975 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
154,981 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2019-07-26 |
4 |
A |
$9.04 |
$7,205 |
D/D |
797 |
152,904 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
28,125 |
179,298 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
50,161 |
223,919 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-06-21 |
4 |
AS |
$27.50 |
$279,165 |
D/D |
(10,000) |
123,436 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, FINANCE & ADMIN, TREAS |
• – – |
2014-05-13 |
4 |
B |
$28.06 |
$28,057 |
D/D |
1,000 |
64,636 |
2.74 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, FINANCE & ADMIN, TREAS |
• – – |
2014-05-14 |
4 |
B |
$26.93 |
$21,544 |
D/D |
800 |
65,436 |
2.74 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, FINANCE & ADMIN, TREAS |
• – – |
2014-05-15 |
4 |
B |
$25.95 |
$18,165 |
D/D |
700 |
66,136 |
2.74 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2017-05-12 |
4 |
B |
$9.18 |
$91,800 |
D/D |
10,000 |
110,227 |
2.74 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2017-03-17 |
4 |
D |
$14.95 |
$5,801 |
D/D |
(388) |
100,227 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2017-08-04 |
4 |
D |
$12.39 |
$2,478 |
D/D |
(200) |
110,803 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-02-05 |
4 |
D |
$23.38 |
$5,003 |
D/D |
(214) |
134,633 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
